SACK1B and breast cancer: Conversely, we found that inhibition of FAM83B from breast cancer cell lines increased CRAF interactions with negative regulatory 14-3-3 proteins, decreased CRAF membrane localization, decreased MEK activity, and decreased tumorigenicity.